07/03/2021 5:10 am Welcome to isteroids.com - BLOG

Thursday 18, Oct 2012

  Wrestling Athlete Accepts Sanction

Posted By
Pin it Share on Tumblr

Wrestling athlete accepts sanction

John Lorenz, of Fountain, Colorado, an athlete in the sport of wrestling, has tested positive for a prohibited substance and accepted a suspension for his anti-doping rule violation, according to a statement by the United States Anti-doping Agency (USADA).

The 31-year-old accepted a two-year period of ineligibility, which began on October 4, 2011, the day he accepted his sanction. A urine sample collected out-of-competition on July 10, 2011 from Lorenz contained Clomiphene that is in the class of Hormone Antagonists and Modulators. Clomiphene (Clomid), a female fertility drug, is commonly used to boost the production of natural hormones such as testosterone immediately before the end of or at the end of an anabolic steroid cycle. It is indicated for the treatment of ovulation dysfunction in women desiring pregnancy by initiating a series of endocrine events culminating in a rise of follicle stimulating hormone (FSH). Clomid is a mixture of two geometric isomers, enclomifene (E-clomifene) and zuclomifene (Z-clomifene) and has been found very effective in the treatment of secondary male hypogonadism and is commonly used as a “recovery drug” and taken toward the end of a steroid cycle and may also result in direct stimulation of the hypothalamic–pituitary–adrenal axis.

Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Federation of Associated Wrestling Styles (FILA) Anti-Doping Regulations, both of which have both adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List, hormone Antagonists and Modulators are prohibited.

The wrestling athlete is also disqualified from all competitive results obtained on and subsequent to July 10, 2011, the day the sample was collected, including forfeiture of any medals, points, and prizes as a result of the sanction. The 31-year-old competed at 211.5 pounds at the U.S. Wrestling world team trials in Oklahoma City in June 2011.

At the 2010 U.S. Open in Cleveland State University’s Wolstein Center, WCAP wrestler Pfc. John Lorenz lost 2-0, 1-0 to six-time national champion Justin Ruiz of New York Athletic Club in the 96-kilo/211.5-pound Greco finale. Lewis after the win said Lorenz is making great progress and it is always good to fight a real fighter. Lorenz came second in the U.S. World Team Trials and third in U.S. Open in 2011 and was second in the U.S. Open and Fifth in Dave Schultz Memorial International in 2010. John Lorenz was fourth in 2009 New York AC International and came sixth in U.S Nationals in 2009 and claimed the sixth spot in the U.S. Nationals in the years 2007 and 2008. In 2001, he came third in Dave Schultz Memorial International, fourth in Sunkist Kids International Open… fourth in New York AC Invitational, and third in University Nationals and competed for LaCrosse Logan HS for Doug LeClair, where he was a State champion in 1998 and 1997 Wisconsin/Minnesota Bi State champion. At the 2011 U.S. World Team Trials, Lorenz won the Challenge Tournament at 96 kilos, beating Justin Millard in the finals and faced Justin Ruiz, a seven-time U.S. Open champion and 2005 World bronze medalist, in the best-of-three finals series.

pdf_iconDownload in PDF: Wrestling Athlete Accepts Sanction

Thursday 16, Feb 2012

  Nolvadex-Tamoxifen Citrate

Posted By
Pin it Share on Tumblr

If you are hesitant to start with an anabolic steroid cycle because of fear of estrogenic side effects such as oily skin or gynecomastia, Nolvadex-Tamoxifen citrate can help you stay free from all possible side effects of estrogens and even restore the natural production of testosterone, the male sex hormone, after the cycle gets over.

Also known as LiquiNolva and Nolva, the antiestrogen is medically prescribed to patients with breast cancer and has the unique ability to reduce the recurrence of breast cancer in women who have had radiation therapy and/or surgery for treating early breast cancer.

The active ingredient in tablets of Nolvadex is tamoxifen citrate and the list of inactive ingredients includes carboxymethylcellulose calcium, magnesium stearate, mannitol, and starch. The molecular weight of Tamoxifen citrate is 563.62 g/mol at the base and its molecular formula is C32H37NO8. It has the chemical name of (Z)2-[4-(1,2-diphenyl-1-butenyl) phenoxy]-N, N-dimethylethanamine 2 hydroxy-1,2,3- propanetricarboxylate (1:1).

Sportsmen or others on steroids use Nolvadex to stay protected against estrogenic side effects like oily skin, acne, gynecomastia, and water retention. In addition to this, Nolvadex is also used for promoting balanced growth and development of muscle and body organs and inhibiting side effects associated with the use of aromatizable steroids such as Dianabol, Anadrol, and derivatives of Testosterone. The use of Nolva is also related to dramatic enhancements in the context of luteinizing hormone, follicle-stimulating hormone, and testosterone when used in daily doses of 20-40 mg for medical purposes and in doses of 20-45 mg per day for other reasons.

Nolvadex is available in oral and injectable forms and can be easily purchased online, with or without a medical prescription. It should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F).